OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Total flavonoids of Broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signaling pathways
Qi Wang, Yunfei Wei, Yeling Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1869, Iss. 5, pp. 159497-159497
Closed Access | Times Cited: 7
Qi Wang, Yunfei Wei, Yeling Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1869, Iss. 5, pp. 159497-159497
Closed Access | Times Cited: 7
Showing 7 citing articles:
Medicinal Potential of Broussonetia papyrifera: Chemical Composition and Biological Activity Analysis
Ying Li, Renhua Huang, Weiwei Zhang, et al.
Plants (2025) Vol. 14, Iss. 4, pp. 523-523
Open Access | Times Cited: 1
Ying Li, Renhua Huang, Weiwei Zhang, et al.
Plants (2025) Vol. 14, Iss. 4, pp. 523-523
Open Access | Times Cited: 1
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities
Yanmei Liao, Fei Lv, Tianwen Quan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Yanmei Liao, Fei Lv, Tianwen Quan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Clinical Insights into Non-Alcoholic Fatty Liver Disease and the Therapeutic Potential of Flavonoids: An Update
Aleksandra Kozłowska
Nutrients (2025) Vol. 17, Iss. 6, pp. 956-956
Open Access
Aleksandra Kozłowska
Nutrients (2025) Vol. 17, Iss. 6, pp. 956-956
Open Access
Differences in Fatty Acid Metabolism between MCDD and HFD Induced Metabolic Dysfunction-associated Fatty Liver Disease Model Mice
Jiaxuan Wang, Xinzhu Liu, Zhen Guo, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Jiaxuan Wang, Xinzhu Liu, Zhen Guo, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease
Wangjing Tan, Junli Zhang, Li Chen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4830-4845
Open Access | Times Cited: 3
Wangjing Tan, Junli Zhang, Li Chen, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4830-4845
Open Access | Times Cited: 3
Cardio-Protective-Promoting Properties of Functional Foods Inducing HDL-Cholesterol Levels and Functionality
Athina Velissaridou, Ellie Panoutsopoulou, Vasileios Prokopiou, et al.
Nutraceuticals (2024) Vol. 4, Iss. 4, pp. 469-502
Open Access | Times Cited: 3
Athina Velissaridou, Ellie Panoutsopoulou, Vasileios Prokopiou, et al.
Nutraceuticals (2024) Vol. 4, Iss. 4, pp. 469-502
Open Access | Times Cited: 3
Potential treatment of glutathione in bullfrogs with abnormal hepatic lipid metabolism revealed by hepatic lipid metabolism and serum metabolomics analysis
Zehui Su, Fu Gao, Rui Shu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Zehui Su, Fu Gao, Rui Shu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
